| | | | | Product | Package Size | EFP | CP | SB | DC | Composition | Registr. Holder | Category | | | | |
---|
|
| | IP | | | Kaliumchlorid 14,9 % B. Braun | 20 x 10 ml | PR | PR | k.A. | | Infusion solution: 2 Active Agents | B. Braun Medical AG | B | FB | | G |  |
| | IP | | | Kaliumchlorid 7,45 % B. Braun | 20 x 20 ml | PR | PR | k.A. | | Infusion solution: 2 Active Agents | B. Braun Medical AG | B | FB | | G |  |
| | IP | | | Kalium chloratum 15% Sintetica | 10 1 ampoule(s) à 10 ml | PR | PR | k.A. | | Infusion preparation: Kalii Chloridum 150 mg/ml | Sintetica SA | B | FB | | G |  |
| | IP | | | KCL 7,45% Sintetica, concentrato per soluzione per infusione (fiala di 50 ml) | ampoule(s) à 50 ml | PR | PR | k.A. | | Concentrate for infusion: 2 Active Agents | Sintetica SA | B | FB | | G |  |
| | IP | | | KCL 7,45% Sintetica, concentrato per soluzione per infusione (fiala di 50 ml) | 10 1 ampoule(s) à 50 ml | PR | PR | k.A. | | Concentrate for infusion: 2 Active Agents | Sintetica SA | B | FB | | G |  |
| | IP | | | Kaliumchlorid Bichsel 15 % | 10 1 Vial(s) à 50 ml | PR | PR | k.A. | | Konzentrat zur Herstellung einer Infusionslösung (Vial): 3 Active Agents | Laboratorium Dr. G. Bichsel AG | B | FB | | G |  |
| | IP | | | Kaliumchlorid 7.5 % | 10 1 Vial(s) à 50 ml | PR | PR | k.A. | | Konzentrat zur Herstellung einer Infusionslösung (Vial): 3 Active Agents | Laboratorium Dr. G. Bichsel AG | B | FB | | G |  |
| | IP | | | KCL 7,45% Sintetica | ampoule(s) à 20 ml | PR | PR | k.A. | | concentrato per soluzione per infusione: Kalii Chloridum 74.5 mg/ml | Sintetica SA | B | FB | | G |  |
| | IP | | | KCL 7,45% Sintetica | 10 1 ampoule(s) à 20 ml | PR | PR | k.A. | | concentrato per soluzione per infusione: Kalii Chloridum 74.5 mg/ml | Sintetica SA | B | FB | | G |  |
|
| | IP | | | Natrium Bicarbonicum Sintetica 8,4 % | 10 1 ampoule(s) à 2 ml | PR | PR | k.A. | | Injection solution: Natrii Hydrogenocarbonas 84 mg/ml | Sintetica SA | B | FB | | G |  |
|
| | IP | | | NaCl 10 % B. Braun | 20 x 10 ml | PR | PR | k.A. | | Infusion solution: 2 Active Agents | B. Braun Medical AG | B | FB | | G |  |
| | IP | | | Natrium chloratum Amino 10% | 10 x 10 ml | PR | PR | k.A. | | Konzentrat für Infusionslösungen: Natrii Chloridum 100 mg/ml | Amino AG, Fabrikation pharmazeutischer und chemischer Produkte | B | FB | | G |  |
| | IP | | | Natrium chloratum Amino 20% | 10 x 10 ml | PR | PR | k.A. | | Konzentrat für Infusionslösungen: Natrii Chloridum 200 mg/ml | Amino AG, Fabrikation pharmazeutischer und chemischer Produkte | B | FB | | G |  |
| | IP | | | Natrium Chloratum Sintetica 10 % | 10 1 ampoule(s) à 10 ml | PR | PR | k.A. | | concentrato di perfusione: Natrii Chloridum 100 mg/ml | Sintetica SA | B | FB | | G |  |
| | IP | | | Natrium Chloratum Sintetica 20 % | 10 1 ampoule(s) à 10 ml | PR | PR | k.A. | | concentrato di perfusione: Natrii Chloridum 200 mg/ml | Sintetica SA | B | FB | | G |  |
| | IP | | | Natrium Chloratum Sintetica 25 % | 10 1 ampoule(s) à 10 ml | PR | PR | k.A. | | concentrato di perfusione: Natrii Chloridum 250 mg/ml | Sintetica SA | B | FB | | G |  |
|
| | IP | | | Magnesiumsulfat Bichsel 10% | 10 1 ampoule(s) à 10 ml | PR | PR | k.A. | | Injection solution: Magnesii Sulfas Heptahydricus 100 mg/ml | Laboratorium Dr. G. Bichsel AG | B | FB | | G |  |
| | IP | | | Magnesiumsulfat Bichsel 20% | 10 1 ampoule(s) à 10 ml | PR | PR | k.A. | | Injection solution: Magnesii Sulfas Heptahydricus 200 mg/ml | Laboratorium Dr. G. Bichsel AG | B | FB | | G |  |
| | IP | | | Magnesiumsulfat Bichsel 50% | 10 1 ampoule(s) à 10 ml | PR | PR | k.A. | | Injection solution: Magnesii Sulfas Heptahydricus 500 mg/ml | Laboratorium Dr. G. Bichsel AG | B | FB | | G |  |
|
| | IP | | | Kaliumphosphat 1 molar B. Braun | 5 1 ampoule(s) à 10 ml | PR | 12.50 | k.A. | | Infusion solution: Kalii Dihydrogenophosphas | B. Braun Medical SA | B | FB | | G |  |
|
| | IP | | | Calrecia 100 mmol/l | 8 x 1500 ml | PR | PR | k.A. | | Infusion solution: Calcii Chloridum | Fresenius Medical Care (Schweiz) AG | B | FB | | G |  |
|
| | IP | | | Magnesiumchlorid 0,5 molar B. Braun | 5 1 ampoule(s) à 10 ml | PR | 8.50 | k.A. | | Infusion solution: Magnesii Chloridum Hexahydricum | B. Braun Medical SA | B | FB | | G |  |
|
| | IP | | | Glycophos | 20 x 20 ml | PR | PR | k.A. | | Solution: 2 Active Agents | Fresenius Kabi (Schweiz) AG | B | FB | | G |  |
|
| | IP | | | Cardioplexol | | PR | PR | k.A. | | Kardioplege Lösung: 3 Active Agents Kardioplege Lösung: Procaini Hydrochloridum | Medius AG | B | FB | | G |  |
|
| | IP | | | Addaven | 20 x 10 ml | PR | PR | k.A. | | Concentrate for infusion: 9 Active Agents | Fresenius Kabi (Schweiz) AG | B | FB | | G |  |
| | IP | | | Nutryelt | 10 x 10 ml | PR | PR | k.A. | | Concentrate for infusion: 9 Active Agents | Baxter AG | B | FB | | G |  |
| | IP | | | Nutryelt Junior 10 ml | 10 x 10 ml | PR | PR | k.A. | | Concentrate for infusion: 5 Active Agents | Baxter AG | B | FB | | G |  |
| | IP | | | Peditrace | 10 1 ampoule(s) à 10 ml | PR | PR | k.A. | | Concentrate for infusion: 6 Active Agents | Fresenius Kabi (Schweiz) AG | B | FB | | G |  |
| | IP | | | Tracutil | 5 1 ampoule(s) à 10 ml | PR | PR | k.A. | | Zusatzampullen für Infusionslösungen: 14 Active Agents | B. Braun Medical SA | B | FB | | G |  |
|
| | IP | | | Dipeptiven | 10 Flasche(n) | PR | PR | k.A. | | Concentrate for infusion: 2 Active Agents | Fresenius Kabi (Schweiz) AG | B | FB | | G |  |
| | IP | | | Dipeptiven | 10 Flasche(n) | PR | PR | k.A. | | Concentrate for infusion: 2 Active Agents | Fresenius Kabi (Schweiz) AG | B | FB | | G |  |
|
| | IP | | | Viant | 5 | PR | PR | k.A. | | Lyophilisate: 13 Active Agents | B. Braun Medical SA | B | FB | | G |  |
| | IP | | | Viant | 10 | PR | PR | k.A. | | Lyophilisate: 13 Active Agents | B. Braun Medical SA | B | FB | | G |  |
L | | IP | | | Cernevit | 10 Durchstechflasche(n) | 65.78 | 87.95 | 10 % | | Injection preparation: 12 Active Agents | Baxter AG | B / SL | FB | | G |  |
| | IP | | | Soluvit N | 10 ampoule(s) | PR | PR | k.A. | | Lyophilisate: 9 Active Agents | Fresenius Kabi (Schweiz) AG | B | FB | | G |  |